Hypovitaminosis D and "Metabolic" Inflammatory Status in Patients With Obesity
ViDO
1 other identifier
observational
208
1 country
1
Brief Summary
Since obesity is related to systemic chronic inflammatory status and hypovitaminosis D, the study aimed to assess the incidence of hypovitaminosis D in obese patients and the correlations between vitamin D levels, inflammation indices, and bioimpedance measures. A retrospective study was conducted on a cohort of obese patients. The inflammation-based prognostic scores, diagnosis of liver fibrosis, systemic inflammatory indices, and bioimpedance measures were analyzed. The linear relationship between vitamin D levels and continuous variables was assessed through the Spearman correlation coefficient, and to determine significant predictors of vitamin D levels a stepwise multiple linear regression was used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Submitted
Initial submission to the registry
October 29, 2023
CompletedFirst Posted
Study publicly available on registry
November 3, 2023
CompletedNovember 7, 2023
November 1, 2023
3.5 years
October 29, 2023
November 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vitamine D plasma level in patients with obesity
To assess the incidence of hypovitaminosis D in a cohort of patients with obesity
enrollment time
Secondary Outcomes (3)
Vitamin D plasma level and systemic inflammation
enrollment time
Vitamin D plasma level and liver fibrosis/inflammation
enrollment time
Vitamine D plasma level and bioimpedance parameters
enrollment time
Interventions
Blood test measured in ng/ml
Measurements of body composition were conducted with Bioelectrical Impedance Analysis (BIA) technique, asking the participants to stand on the device barefoot to complete the analysis. Among all parameters, BMI, phase angle (PhA), total body water (TBW), extracellular (ECW) and intracellular water (ICW), body fat index, and fat and muscular mass were recorded.
Ferritin plasma levels were measured in μg/L
CRP plasma levels were measured in mg/L
Glasgow Prognostic Score/modified Glasgow Prognostic Score (GPS/mGPS), Prognostic Nutritional Index (PNI), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte ratio (PLR), Lymphocyte-to-monocyte ratio (LMR), Systemic immune-inflammation index (SII) were calculated using blood test results
A liver biopsy was used to study nonalcoholic steatohepatitis (NASH) and fibrosis according to the Kleiner-Brunt classification
Eligibility Criteria
Patients with obesity eligible for bariatric surgery
You may qualify if:
- BMI\> 35 Eligible for bariatric surgery according to the current international guidelines (IFSO guidelines)
You may not qualify if:
- Patients affected by active liver viral infection
- Patient alcohol or drug addicted
- Incompetent patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Silvia Palmisano
Trieste, 34100, Italy
Biospecimen
Liver biopsies were studied to analyze fibrosis and inflammation grade
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Silvia Palmisano, MD
University of Trieste
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
October 29, 2023
First Posted
November 3, 2023
Study Start
January 1, 2018
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
November 7, 2023
Record last verified: 2023-11